Image

Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib

Improved skin care for lung cancer patients on Amivantamab and Lazertinib.

Recruiting
18 years and older
All
Phase 2

This study aims to see if better skin care can help reduce skin problems like rash and paronychia (a painful finger or toe infection) in patients with a type of lung cancer called non-small cell lung cancer (NSCLC). This cancer is linked to changes in a gene called epidermal growth factor receptor (EGFR). Patients will be treated with two medicines, *amivantamab* and *lazertinib*, which are given as first-line, or initial, treatments. The study checks if enhanced skin care is better than standard care at preventing skin issues.

To join, you should have advanced or spreading NSCLC with specific gene changes. You can't have uncontrolled health issues or certain lung diseases. Also, if you have allergies to the study drugs, you can't participate. The study will last for a certain period, with regular check-ups to monitor your skin and overall health.

  • Participants must have specific gene changes in their lung cancer.
  • Regular check-ups required to track skin and health.
  • Cannot join if you have certain lung diseases or allergies to study drugs.
Study details
    Carcinoma
    Non-Small-Cell Lung

NCT06120140

Janssen Research & Development, LLC

8 March 2025

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.